Valeo Pharma Launches Redesca and Redesca HP (LMHW biosimilar) in Canada
Shots:
- Valeo has started commercial shipment of Redesca and Redesca HP- its low molecular weight heparin ("LMWH") biosimilar across Canada
- The LMWH is being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism and is now increasingly used as a 1L of defense tool in the fight against COVID-19
- Redesca is a low molecular weight heparin biosimilar
Ref: PRNewswire | Image: Valeo
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com